Alebund licenses kidney drug AP306 to R1 Therapeutics outside China
Go back to Alebund licenses kidney drug AP306 to R1 Therapeutics outside China| DaVita Inc. (NYSE: DVA) | Delayed: 217.04 +3.68 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $213.36 | 52 Week High | $78.77 | |||
| Open | $212.23 | 52 Week Low | $55.00 | |||
| Day High | $217.04 | P/E | 75.10 | |||
| Day Low | $212.22 | EPS | $2.89 | |||
| Volume | 1,669,478 | |||||
